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A AB BS ST TR RA AC CT T
B Ba ac ck kg gr ro ou un nd d: : We have reported 1-year outcomes and
antacid medication use in 100 patients undergoing laparo-
scopic Nissen fundoplication. As a follow-up study, we
queried these same patients to determine whether their out-
comes endured 4 years after fundoplication.
M Me et th ho od ds s: : One hundred patients undergoing laparoscop-
ic Nissen fundoplication between 1992 and 1997 were
asked, at 1 to 2 years and 4 to 6 years postoperatively, to
grade their symptoms on a scale of 1 (mild) to 10
(severe). Patients were also queried as to the
number/cost of antacid medications used before and
after fundoplication.
R Re es su ul lt ts s: : Significant improvements were noted in symp-
toms of heartburn, postprandial emesis, gas/bloating,
and dysphagia after fundoplication. Significant decreases
in antacid medication use (97% vs 19%) and monthly
costs ($168±$91 vs $30±$54) were seen following fundo-
plication. The number of patients on antacid medications
and the monthly costs of these medications (37% and
$53±$87, respectively) increased significantly from early
to late follow-up, but were still significantly lower than
those before surgery. Overall, 87% and 90% of patients
were pleased with their outcome at early and late follow-
up, respectively, and 93% and 92% of patients stated they
would consider undergoing fundoplication again if nec-
essary (P=NS). 
C Co on nc cl lu us si io on n: : Laparoscopic Nissen fundoplication results in a
significant reduction in the symptoms of reflux and the use
of antacid medications with a high degree of patient satisfac-
tion. Although some patients return to antacid medications at
late follow-up, they continue to have few symptoms and are
pleased with their outcomes.
K Ke ey y   W Wo or rd ds s: : GERD, Reflux, Nissen, Outcomes.
I IN NT TR RO OD DU UC CT TI IO ON N
Heartburn is one of the most common chronic disorders
affecting the gastrointestinal tract.1 Due to the spectrum
and variation of symptoms, the prevalence of gastroe-
sophageal reflux disease (GERD) is difficult to define;
however, surveys have shown that heartburn and acid
regurgitation are experienced by approximately 20% of
the United States population at least once per week.1,2
GERD has been shown to significantly affect patients’
quality of life3-5 and is a potential risk factor for adeno-
carcinoma of the esophagus.6-8 Traditionally, GERD has
been managed initially with a combination of dietary
changes, antacids, H2-antagonists, and more recently,
proton pump inhibitors.9 Surgical management is gener-
ally reserved for patients with persistent symptoms on
maximal medical therapy or patients with complications
of GERD, such as esophageal ulcer, esophageal stricture,
Barrett’s esophagus, or aspiration pneumonia.10
Laparoscopic Nissen fundoplication is well established as
an effective surgical therapy for the treatment of GERD,
yielding substantial symptomatic improvement and reduc-
tions in the use and cost of antacid medications.11-15 The
durability of these gains, however, have recently been
called into question, as failures in surgical therapy have
become more apparent.16-20
In 1996, we queried our first 100 consecutive patients
who underwent laparoscopic Nissen fundoplication to
determine the patients’ subjective measurement of their
reflux symptoms before and after fundoplication, as well
as the monthly cost of medications used to treat these
symptoms.15 Significant improvement in the patients’
evaluation of their typical and atypical GERD symptoms
was seen, as well as significant savings in monthly
antacid medication costs at a mean follow-up of 9
months.
In our original study, we noted that 20% of patients con-
tinued to use antacid medications following laparoscop-
ic Nissen fundoplication (vs 97% before surgery), though
significantly fewer medications were being taken per
patient (0.3±0.6 vs 1.8±0.9) at a significantly reduced
monthly cost ($30±$54 vs $170±$91). These patients stat-
ed that their symptoms were significantly improved rela-
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tive to before fundoplication and that they were pleased
with their outcomes. As a follow-up study, we queried
the same 100 patients to determine whether the docu-
mented improvements in symptoms endured over time
and to elucidate the pattern of antacid medication use at
long-term follow-up. Our hypothesis in undertaking this
study was that patients would continue to have similar
and significant improvements in symptoms compared
with those before fundoplication as seen at early follow-
up and that antacid medication use would remain rela-
tively constant compared with that reported in our first
study.
M ME ET TH HO OD DS S
P Pr re eo op pe er ra at ti iv ve e   A As ss se es ss sm me en nt t
Preoperatively, all patients were evaluated with
esophageal manometry and 24-hour ambulatory pH mon-
itoring. Criteria for surgical intervention were (1) a
DeMeester score greater than 14.72,21 (2) a good correla-
tion between symptoms and reflux episodes, (3) contin-
ued symptoms in the face of maximum medical treatment
or patient preference for fundoplication, (4) adequate
esophageal motility to allow construction of a “valve” at
the gastroesophageal junction, and (5) being an appro-
priate operative candidate.
L La ap pa ar ro os sc co op pi ic c   N Ni is ss se en n   F Fu un nd do op pl li ic ca at ti io on n
Our approach to laparoscopic Nissen fundoplication has
previously been described.15 Briefly, all operations were
undertaken using 5 trocars. The right and left crura were
exposed and the distal esophagus circumferentially dis-
sected using a Harmonic scalpel (Ethicon Endosurgery,
Cincinnati, OH). The anterior and posterior vagus nerves
were identified and preserved. The gastric fundus was
widely mobilized by dividing the short gastric vessels
with the Harmonic scalpel. When present, the hiatal her-
nia was reduced and the hernia sac divided or removed.
Eight centimeters of esophagus were reduced into the
peritoneal cavity, and a floppy 2.5- to 3.0-cm fundoplica-
tion was undertaken over a 52 to 60 F bougie. Bougie
size was determined by body habitus using a 52 to 56 F
in females and 56 to 60 F in males. The wrap was tacked
with 4 interrupted sutures, the first 2 of which incorpo-
rated the esophagus. The wrap was always located above
the gastroesophageal junction and buttressed to the right
crus to minimize tension and prevent breakdown. The
esophageal hiatus was reconstructed when necessary, but
all patients had at least 1 suture placed between the left
and right crura to prevent postoperative dilation of the
esophageal hiatus.
P Po os st to op pe er ra at ti iv ve e   M Ma an na ag ge em me en nt t
Patients were started on a liquid diet on the day of the
operation and advanced to a soft mechanical diet on the
morning of the first postoperative day. Patients were gen-
erally discharged within 24 to 48 hours once tolerating a
soft diet with instructions to advance to a regular diet at
home over the ensuing week.
F Fo ol ll lo ow w- -u up p   a an nd d   S Su ur rv ve ey y
Patients were seen at the clinic within 2 weeks of the
operation, then at 3, 6, and 12 months, and as needed
thereafter. At each visit, patients were asked to complete
a questionnaire designed to assess patient satisfaction,
medication use, and symptoms. Patients who did not
return for follow-up received questionnaires by mail or
were contacted by telephone. Using a Likert scale that
ranks symptoms numerically as least (“1”) to most (“10”)
bothersome, patients were asked to grade a variety of
symptoms related to typical and atypical GERD. The
questionnaire also asked patients to list all medications
and dosages, monthly antacid medication costs, and any
changes in sleeping habits or diet instituted to prevent
GERD symptoms. Overall satisfaction with the operative
experience, including hospitalization, postoperative con-
valescence, and postoperative symptoms were graded as
very satisfied, satisfied, indifferent, unsatisfied, or very
unsatisfied. Finally, patients were asked whether or not
they were pleased with their postoperative outcome.
Four years after the initial survey, identical question-
naires were mailed to the entire series of patients. Those
patients who did not respond to the mailed question-
naires were surveyed by telephone by an examiner
blinded to the previous outcomes.
S St ta at ti is st ti ic ca al l   A An na al ly ys si is s
Patient responses were entered into a database
(Microsoft Excel) and statistical analysis was undertaken
using True Epistat (Epistat Serviced, Richardson, TX).
Data were compared using the Student t test, chi-square
analysis, or Fisher’s exact test. Significance was accepted
with 95% confidence. Data are presented as mean±SD,
when appropriate.R RE ES SU UL LT TS S
D De em mo og gr ra ap ph hi ic cs s
Between 1993 and 1997, 100 consecutive patients under-
going laparoscopic Nissen fundoplication completed
questionnaires a mean 9±8 months after surgery. During
the second follow-up period, 84 of the 100 patients
returned questionnaires or were contacted by telephone
(mean follow-up 50±12 months). These patients on aver-
age were in their sixth decade, and 51% of the patients
were males ( (T Ta ab bl le e   1 1) ). Of the patients lost to follow-up,
3 died of unrelated causes and 13 were unable to be
located. Ten patients had undergone previous fundopli-
cation at the time of entry into the study. Mean time to
reoperation for these patients was 22±13 months.
C Co om mp pl li ic ca at ti io on ns s
Twenty-nine complications occurred during the periop-
erative period, including 3 fundal tears, two of which
were recognized and repaired intraoperatively ( (T Ta ab bl le e   2 2) ).
The third fundal tear was not recognized until the post-
operative period when the patient developed intraab-
dominal sepsis. This patient died after a prolonged hos-
pital stay and represents the only death in the series.
Atelectasis was the most common complication and did
not result in significant clinical sequelae. Pneumothorax
occurred rarely and was treated by aspiration with a
small catheter at the time of surgery or in the recovery
room. One patient was noted to have a small area of
ischemia at the tip of the spleen, which was of no clini-
cal consequence. During the follow-up period, an addi-
tional 12 complications occurred. Incisional hernias at
trocar sites were the most common long-term complica-
tion and occurred in 8 (9%) patients. Failure of fundopli-
cation occurred in 4 patients (hiatal failure in 2, fundo-
plication disruption in 2), all of which underwent laparo-
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scopic revision a mean 23±12 months after the original
fundoplication. In all, 10 patients required reoperation
during follow-up (incisional herniorrhaphy 7, fundopli-
cation revision 3, incisional herniorrhaphy plus fundopli-
cation revision 1). Three operations were converted to
“open” to improve exposure (n=2) or to repair a fundal
tear (n=1).
M Me ed di ic ca at ti io on n   U Us se e
Antacid medication use decreased significantly in the
early follow-up period and has remained significantly
decreased at long-term follow-up when compared with
T Ta ab bl le e   1 1. .
Demographics of Patients Undergoing Laparoscopic Nissen Fundoplication
Early Follow-up Late Follow-up
Age in years (range) 51 (15-77) 54 (19-79)
Sex 48 Male/52 Female 41 Male/43 Female
Mean follow-up (months) 9±8* 50±12*
*Mean±SD
T Ta ab bl le e   2 2. .
Complications Following Laparoscopic Nissen Fundoplication
Perioperative (Total = 29)
Complication Number
Atelectasis 6
Esophageal spasm 4
Fundal tear 3
Pneumothorax 3
Diarrhea 3
Abdominal pain 3
Bezoar 1
Splenic demarcation 1
Atrial fibrillation 1
Pneumonia 1
Intrahepatic abscess 1
Minor GI hemorrhage 1
Hyperemesis 1
Follow-up (Total = 12)
Incisional hernia 8
Hiatus failure 2
Wrap disruption 2Symptoms and Antireflux Medication Use Following Laparoscopic Nissen Fundoplication: Outcome at 1 and 4 Years, Bloomston M et al.
214 JSLS(2003)7:211-218
that before surgery ( (T Ta ab bl le e   3 3) ). The use of each individual
antacid medication was significantly reduced compared
with that before surgery at the time of each follow-up sur-
vey. This decreased medication use remained constant
during the follow-up period. At long-term follow-up,
however, proton pump inhibitor use was significantly
increased compared with that at early follow-up, though
the use of this medication remained reduced from that at
preoperative levels (P<0.0001). The subgroup of patients
taking medications at late follow-up used fewer medica-
tions after follow-up [1.7 medications/person preopera-
tively vs 1.1 medications/person at late follow-up
(P<0.00001)] and reported a mean savings of $63±$88 per
person per month from their preoperative medication
costs (P<0.01). At late follow-up, fewer patients were
using antacids or promotility agents compared with that
in both early follow-up and before fundoplication. These
substantial reductions in medication use resulted in a sig-
nificant decrease in monthly antacid medication costs to
the patients.
D Di ie et t   a an nd d   S Sl le ee ep pi in ng g   H Ha ab bi it ts s
Laparoscopic Nissen fundoplication significantly improv-
ed self-imposed dietary restrictions and sleeping habits of
patients at early and late follow-up. Preoperatively, 56%
of patients stated that coffee aggravated their symptoms.
Following fundoplication, 83% of patients reported no
symptoms when drinking coffee, with another 13%
reporting improvement in these symptoms. This
remained unchanged at long-term follow-up. Similarly,
86% of patients avoided certain foods before fundoplica-
tion for fear of exacerbating their symptoms, and 87%
found it necessary to alter their sleeping habits before
fundoplication to avoid symptoms (eg, place a block
under the head of the bed). After surgery, only 20% of
patients continued to abstain from certain foods, and
83% were able to return to their original, preferred sleep-
ing habits. No significant changes were observed in these
habits at long-term follow-up as 79% of patients did not
need to alter their diet, and 80% of patients did not need
to modify their sleeping habits at the time of the second
survey.
R Re ef fl lu ux x   S Sy ym mp pt to om ms s
Patients reported significant improvements in all GERD
symptoms at the time of the initial survey, and these
improvements were maintained at the time of the late
follow-up ( (T Ta ab bl le e   4 4) ). Prior to fundoplication, the most
bothersome symptom reported was heartburn, both post-
prandial and nocturnal. Heartburn, along with postpran-
dial vomiting, was uncommon and the least bothersome
following surgical intervention, and these gains remained
constant throughout the follow-up period. Significant
improvement was noted postoperatively for all symp-
toms except the inability to belch or vomit, which were
similar to preoperative values at long-term follow-up.
Initially, patients reported a significant inability to belch,
but this symptom returned to baseline by late follow-up.
Bloating was the most bothersome symptom reported
following fundoplication although, surprisingly, it was
T Ta ab bl le e   3 3. .
Antacid Medication Use and Monthly Costs to Patients Before and After Laparoscopic Nissen Fundoplication
Preoperative Early Follow-up Late Follow-up
Patients taking antacid medications 97 (97%) 19 (19%)* 31 (37%)*†
PPI‡ 59 (59%) 8 (8%)* 26 (31%)*†
H2-antagonist‡ 46 (46%) 4 (4%)* 1 (1%)*
OTC antacid‡ 22 (22%) 7 (7%)* 1 (1%)*
Promotility agent 30 (30%) 8 (8%)* 3 (4%)*
Antacid medications/patient§ 1.82 ± 0.9 0.3 ± 0.6* 0.4 ± 0.6*
Antacid medication costs§ $168 ± $91 $30 ± $54* $53 ± 87*†
*P<0.01 vs preoperative.
†P<0.05 vs early follow-up.
‡PPI=Proton pump inhibitor, H2= histamine receptor type 2, OTC=over the counter.
§Data are mean ± SD.
||Medication costs are monthly costs of antacid medications per patient.significantly improved from preoperative levels. Patients
reported continued improvement in the sensation of
food sticking in the chest over the course of the study as
this symptom was reported to be significantly less both-
ersome at long-term follow-up compared with that
before surgery and at early follow-up.
P Pa at ti ie en nt t   S Sa at ti is sf fa ac ct ti io on n
Overall, 74 (88%) respondents were satisfied or very sat-
isfied with their operative experience at the time of late
follow-up, which was equal to the 88% satisfaction rate
of the initial survey ( (T Ta ab bl le e   5 5) ). Of the 6 (7%) patients
who reported dissatisfaction with their operation at the
time of late follow-up, the only complaints reported were
related to operative experience, not symptoms. Overall,
87% and 90% of patients stated that they were pleased
with their outcome at early and late follow-up, respec-
tively, while 93% and 92% of patients stated they would
consider undergoing the operation again under similar
circumstances.
D DI IS SC CU US SS SI IO ON N
The efficacy of Nissen fundoplication in the management
of patients with severe gastroesophageal reflux is well
established. To many nonsurgeons, the perceived exces-
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sive morbidity associated with celiotomy and fundoplica-
tion limited referrals for fundoplication to the most com-
plex and severe cases of reflux.18 The introduction of
minimally invasive techniques along with the apparent
epidemic of adenocarcinoma of the distal esophagus
have served to promote the application of antireflux sur-
gery. Although laparoscopic Nissen fundoplication has
rapidly gained wide acceptance, the surgical community
continues to endeavor to “fine tune” the operation to
optimize long-term results. In this study, we have sought
to determine whether the favorable outcomes generally
achieved early after laparoscopic Nissen fundoplication
endure over time. To address this, we focused on
patients’ perceptions of symptoms and outcomes by sur-
veying our first 100 patients at 2 time points approxi-
mately 1 and 4 years after fundoplication.
The patients in this study were generally middle-aged
without a gender bias. At the time of late follow-up, 16
patients were not available to survey. These patients
were aggressively sought by all means available but were
unable (or unwilling) to be found. It is difficult to predict
how this attrition affects the results of the study. In our
experience with other follow-up surveys, we have found
that although some patients who are doing well tend not
to return questionnaires or participate in surveys, a seem-
ingly equal number of patients with suboptimal out-
T Ta ab bl le e   4 4. .
Symptom Severity as Reported by Patients*†
Symptom Preoperative Early Follow-up Late Follow-up
Postprandial heartburn 8.2±2.9 1.5±1.6‡ 1.5±1.5‡
Nocturnal heartburn 7.8±3.3 1.3±0.9‡ 1.6±1.9‡
Postprandial nausea 5.2±4.3 1.7±2.1‡ 1.7±2.0‡
Postprandial emesis 4.3±4.2 1.2±1.3‡ 1.2±1.4‡
Sensation of food stuck in throat 4.9±3.9 2.4±2.6‡ 2.3±2.5‡
Sensation of food stuck in chest 4.9±2.9 2.7±2.8‡ 2.0±2.0‡§
Chest pain with swallowing 4.3±3.9 2.0±2.2‡ 1.7±1.9‡
Difficulty swallowing 4.1±3.8 2.4±2.7‡ 1.9±2.2‡
Asthma/coughing 4.1±4.0 2.0±2.2‡ 2.6±3.1‡
Gas/bloating 6.1±3.8 4.9±3.7‡ 3.9±3.6‡
Inability to vomit 2.4±3.1 2.9±3.5 2.8±3.4
Inability to belch 2.6±3.1 3.8±3.5‡ 2.7±3.2§
*Scale is 1 (least bothersome) to 10 (most bothersome).
†Data are mean±SD.
‡P<0.05 vs preoperative. 
§P<0.05 vs early follow-up; Scale is 1 (least bothersome) to 10 (most bothersome).Symptoms and Antireflux Medication Use Following Laparoscopic Nissen Fundoplication: Outcome at 1 and 4 Years, Bloomston  M et al.
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comes refuse to participate as well. Any assumptions
about the patients in this study lost to follow-up, there-
fore, would be speculative.
Complications did occur with notable frequency but were
generally minor and of no long-term consequence. One
death occurred. The patients in this study include our
early experience with laparoscopy and reflect our pro-
gression along the “learning curve.”  Three fundal tears
did occur, one of which resulted in death. Also, 3 patients
required conversion to open procedures. Incisional her-
nias occurred more often than would have been expect-
ed and with an incidence slightly higher than that report-
ed in the literature.22 This again reflects our early experi-
ence with laparoscopy, as we now routinely close the fas-
cia at all port sites. Finally, 4 patients presented nearly 2
years after fundoplication with demonstrable evidence of
operative failure. These were all revised laparoscopically
with good outcomes.
Antacid medication use dropped dramatically following
fundoplication and remained significantly reduced
throughout the follow-up period. The incidence of med-
ication use did not fall to zero. In the early postoperative
period, the patients tended to take these medications out
of habit or misinformation (ie, they did not know they
were supposed to stop taking them). A notable number
of patients took antacid medications for symptoms
assumed by the patients or prescribing physicians to be
related to continued or recurrent reflux. In the later peri-
ods of follow-up, what is more disturbing is that with
time, significantly more patients resumed antacid med-
ication use, often at the discretion of their primary care
physician without surgical consultation or objective evi-
dence of recurrent reflux or failed fundoplication. To
many patients and referring physicians, it is certainly eas-
ier to undergo a trial of proton pump inhibitors than to
undergo barium esophagraphy, endoscopy, manometry,
24-hour ambulatory pH monitoring, or surgical consulta-
tion. Nonetheless, patients continue to realize significant
monthly cost savings 4 years after fundoplication.
Improvements in patients’ symptoms were common and
endured. Heartburn, both postprandial and nocturnal,
was by far the most problematic symptom for patients
prior to fundoplication. After surgery, the severity of
heartburn was significantly reduced such that it was the
least problematic symptom with the exception of post-
prandial emesis, which was even less severe. This held
true at both early and late follow-up. Significant improve-
ments were recognized in every typical and atypical
symptom category except the inability to vomit and
belch, which actually worsened early on and returned to
preoperative levels at late follow-up. Symptoms of bloat-
ing, gaseousness, and the inability to belch are expected
outcomes that improve with time, but, to our surprise,
were actually less severe after fundoplication. We have
found it helpful to warn patients in advance about these
T Ta ab bl le e   5 5. .
Patient Satisfaction Following Laparoscopic Nissen Fundoplication
Early Follow-up Late Follow-up
Overall satisfaction
Very satisfied 70 (70%) 59 (70%)
Satisfied 18 (18%) 15 (18%)
Indifferent 5 (5%) 4 (5%)
Dissatisfied 3 (3%) 6 (7%)
Very dissatisfied 4 (4%) 0
Are you pleased with your outcome?
Yes 87 (87%) 76 (90%)
No 13 (13%) 8 (10%)
Would you have the operation again?
Yes 60 (60%) 65 (77%)*
No 7 (7%) 7 (8%)
Maybe 33 (33%) 12 (15%)*
*P<0.05 vs early follow-up.symptoms, which usually persist for 3 or 4 weeks after
fundoplication until patients unlearn the aerophagia that
they developed subconsciously over time to clear the dis-
tal esophagus of refluxed gastric contents. Symptoms
continued to improve with time such that, at late follow-
up, symptom scores remained significantly and drastical-
ly reduced compared with those before surgery.
The improvements seen in symptoms translated into gen-
eral satisfaction with the operation and outcomes. An
identical proportion of patients were either satisfied or
very satisfied at early and late follow-up. The few
patients that were very dissatisfied at early follow-up
improved slightly at late follow-up but remained dissatis-
fied, and 1 patient was lost to follow-up. Overall, a high
degree of satisfaction was seen in patients at early fol-
low-up, which endured with time. Interestingly, although
the distribution of patients satisfied/pleased with their
outcomes did not significantly change with time, signifi-
cantly more patients stated that they would undergo the
operation again.
As laparoscopic Nissen fundoplication continues to be
applied more often, its efficacy as a permanent treatment
for the symptoms of GERD is becoming more evident.
Difficulty remains in defining successful outcomes. Routine
postoperative ambulatory pH monitoring is difficult if not
impossible to acquire due to patient reluctance, particular-
ly in the absence of symptoms. Recurrence of symptoms
and development of new symptoms, on the other hand, is
often quickly ascribed to recurrent reflux without objective
evidence or in the face of a poor correlation with ambula-
tory pH studies. Finally, the empiric application and appar-
ent benefit of antacid medications may be due to the place-
bo effect. These medications, however, are often taken
without much benefit. This is not to downplay the surpris-
ing number of patients taking antacid medications at late
follow-up but to emphasize the importance of interpreting
the implications of resumption of antacid medication use.
Although approximately one third of patients were taking
these medications on at least a part-time basis, they report-
ed significant improvements in symptoms and overall sat-
isfaction with their outcomes. They take fewer medications
at a lower monthly cost while returning to their normal
diets and sleeping habits. In short, a patient taking 1 pill 2
to 3 times per week while eating foods without restrictions
and no longer requiring blocks under the head of their
beds to sleep should not be deemed a failure of fundopli-
cation.
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In conclusion, patients note that laparoscopic Nissen fun-
doplication is effective in reducing the life-altering symp-
toms of gastroesophageal reflux. While antacid medica-
tion use tends to increase with time, patients remain
happy with their outcomes and would willingly undergo
fundoplication again, should it be required.
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